The impact of the systemic inflammatory response on hepatic bacterial elimination in experimental abdominal sepsis

Abstract

Background Bacterial translocation from the gut has been suggested to induce a systemic inflammatory response syndrome (SIRS) and organ dysfunction. The liver has a pivotal role in eliminating circulating bacteria entering from the gut. We investigated whether pre-existing inflammation affects hepatic bacterial elimination. Methods Fifteen anaesthetised piglets were infused with E. coli in the portal vein for 3 h. The naive group ( n = 6) received the bacterial infusion without endotoxin exposure. SIRS (SIRS group, n = 6) was induced by endotoxin infusion 24 h before the bacterial infusion. For effects of anaesthesia, controls ( n = 3) received saline instead of endotoxin for 24 h. Bacterial counts and endotoxin levels in the portal and hepatic veins were analysed during bacterial infusion. Results The bacterial killing rate was higher in the naive group compared with the SIRS group ( p = 0.001). The ratio of hepatic to portal venous bacterial counts, i.e. the median bacterial influx from the splanchnic circulation, was 0.06 (IQR 0.01–0.11) in the naive group and 0.71 (0.03–1.77) in the SIRS group at 3 h, and a magnitude lower in the naive group during bacteraemia ( p = 0.03). Similar results were seen for hepatic endotoxin elimination. Peak log tumour necrosis factor alpha was higher in the naive 4.84 (4.77–4.89) vs. the SIRS group 3.27 (3.26–3.32) mg/L ( p < 0.001). Conclusions Our results suggest that hepatic bacterial and endotoxin elimination is impaired in pigs with pre-existing SIRS while the inflammatory response to bacterial infusion is diminished. If similar mechanisms operate in human critical illness, the hepatic elimination of bacteria from the gut could be impaired by SIRS. Electronic supplementary material The online version of this article (10.1186/s40635-019-0266-x) contains supplementary material, which is available to authorized users.

Expression and role of ABIN1 in sepsis: In vitro and in vivo studies

“…Sepsis is defined as severe systemic inflammatory reaction, it contributes to multiple tissues and organ dysfunction, and the process is intricate [ 1 , 2 ]. Currently, the morbidity and mortality of sepsis remain high around the world.…”

Enhanced bacterial clearance in early secondary sepsis in a porcine intensive care model

“…In ESS this trapping mechanism may be more important than other bacterial removal processes. In the liver there is an active uptake of bacteria from the blood 23 , 24 and it has recently been shown that this uptake is reduced in secondary sepsis 25 , which might promote a lower bacterial growth in the liver. Particularly noteworthy is that the significant correlation between bacterial growth in the liver and spleen as demonstrated in PS, suggesting related control of the host defence mechanisms, is not observed in ESS despite reduced growth in the spleen and a similar trend in the liver.…”

The Effect of Colistin Administration as Medicated Feed on Alanine Aminotransferase and Creatinine Level in Broiler Infected with Escherichia coli

“…Kupffer cells, macrophages present in the liver, efficiently phagocyte pathogens and PAMPs that enter the liver via arterial or portal circulation or translocation (migration of active bacteria or bacterial products Creatinine level mg/dl from the intestinal lumen to normal sterile tissue) has been known to induce and guard against systemic resistance. In animals infected with E. coli, the elimination of E. coli is slow, while the release of endotoxin is high so that it influences the hepatic and systemic circulation [4] . An increase in ALT can be caused by the direct effect of bacterial toxins, drugs, chemicals on liver cells, especially those that are closed to the central vein.…”